Showing results (171-180 of 645) with videos related to
Sort By:
Pageof 65
International Cancer Conference Journal|June 1, 2019
A case of advanced pancreatic neuroendocrine tumor in which octreotide long-acting repeatable was effective after failure of everolimus and sunitinibHironori Kitade, Koushiro Ohtsubo, Kengo Hokkoku, et al.International Cancer Conference Journal|June 1, 2019
Uterine leiomyosarcoma well-controlled with eribulin mesylateEtsuko Fujimoto, Kazuhiro Takehara, Tamaki Tanaka, et al.International Cancer Conference Journal|June 1, 2019
Spontaneous regression of a carcinoid tumor that required resection owing to its reappearance and subsequent enlargement after 2 years: a case reportTsuyoshi Uchida, Hirochika Matsubara, Aya Sugimura, et al.International Cancer Conference Journal|June 1, 2019
Erlotinib and bevacizumab combination therapy for afatinib-refractory leptomeningeal carcinomatosis from EGFR-mutated lung cancerMiyuki Abe, Atsushi Osoegawa, Takashi Karashima, et al.International Cancer Conference Journal|June 1, 2019
Re-introducing the same chemotherapy after exposure to anti-PD-1 therapyTakashi Koyama, Motoo Nomura, Doi Keitaro, et al.International Cancer Conference Journal|June 1, 2019
Adenocarcinoma of intestinal type of the vulvaTomoko Kurita, Yusuke Matuura, Masanori Hisaoka, et al.International Cancer Conference Journal|June 21, 2019
Successful treatment of advanced gastric cancer with liver metastasis by S-1 + CDDP and S-1 therapy without surgeryYuichiro Tanishima, Yuya Nyumura, Tomoko Nakayoshi, et al.International Cancer Conference Journal|June 21, 2019
Simultaneous chylous ascites and chylothorax during ramucirumab plus docetaxel chemotherapy in a patient with non-small lung cell cancerMakoto Arai, Susumu Maruta, Meng Meng Fan, et al.International Cancer Conference Journal|October 3, 2022
Pancreatic-pleural fistula from tail pseudocyst in a patient with pancreatic head cancer: a case reportJin Shiraishi, Kyohei Yugawa, Shigeyuki Nagata, et al.International Cancer Conference Journal|October 3, 2022
Long-term treatment with ALK inhibitors for postoperative recurrence of ALK-rearranged lung cancerKen Kodama, Yukio Kimura, Toru Momozane, et al.Pageof 65